ROCKVILLE, MD and KYOTO, JAPAN--(Marketwire - July 28, 2008) - Seegene, Inc. and Shimadzu Corporation today announced a strategic partnership to combine Seegene's Seeplex® multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu's MultiNA high-speed electrophoresis system to provide a highly sensitive, high-throughput multi-pathogen detection and analysis solution.
